Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized Phase III Study of Adjuvant Oncophage® Versus Observation in Subjects With High Risk of Recurrence After Surgical Treatment for Renal Cell Carcinoma

NCT00033904 is registered in ClinicalTrials.gov with Agenus Inc. as lead sponsor.

NCT NCT00033904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00033904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized Phase III Study of Adjuvant Oncophage® Versus Observation in Subjects With High Risk of Recurrence After Surgical Treatment for Renal Cell Carcinoma
Lead sponsor
Agenus Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2000
Completion date
April 30, 2007
Enrollment
650
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma